Loading...
XASE
INFU
Market cap122mUSD
Jul 29, Last price  
5.86USD
1D
-0.68%
1Q
24.15%
Jan 2017
129.80%
IPO
8.52%
Name

InfuSystem Holdings Inc

Chart & Performance

D1W1MN
P/E
52.42
P/S
0.91
EPS
0.11
Div Yield, %
—
Shrs. gr., 5y
0.82%
Rev. gr., 5y
10.70%
Revenues
135m
+7.22%
006,582,00035,415,00038,964,00047,229,00054,637,00058,828,00062,280,00066,487,00072,125,00070,497,00071,077,00067,138,00081,115,00097,388,000102,382,000109,914,000125,785,000134,861,000
Net income
2m
+168.92%
-24,783-7,859,344-2,796,0009,959,000774,000-1,852,000-45,443,000-1,489,0001,669,0003,357,0003,743,000-222,000-20,707,000-1,095,0001,361,00017,332,0001,420,00018,000872,0002,345,000
CFO
20m
+82.30%
-76-912,3534,377,00010,897,0009,708,00010,812,0007,172,0005,452,0007,463,0007,255,0007,054,0007,909,0007,583,00011,391,00013,875,00020,280,00018,316,00017,517,00011,223,00020,459,000
Earnings
Aug 06, 2025

Profile

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
URL
https://ir.infusystem.com/
IPO date
Jun 15, 2006
Employees
420
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
134,861
7.22%
125,785
14.44%
109,914
7.36%
Cost of revenue
126,979
120,707
105,679
Unusual Expense (Income)
NOPBT
7,882
5,078
4,235
NOPBT Margin
5.84%
4.04%
3.85%
Operating Taxes
2,714
979
112
Tax Rate
34.43%
19.28%
2.64%
NOPAT
5,168
4,099
4,123
Net income
2,345
168.92%
872
4,744.44%
18
-98.73%
Dividends
Dividend yield
Proceeds from repurchase of equity
(1,996)
(1,311)
(5,297)
BB yield
1.09%
0.57%
2.83%
Debt
Debt current
1,474
931
Long-term debt
9,120
40,699
40,679
Deferred revenue
27,496
Other long-term liabilities
23,864
(33,157)
Net debt
8,593
41,942
(2,760)
Cash flow
Cash from operating activities
20,459
11,223
17,517
CAPEX
(1,092)
(1,024)
(15,076)
Cash from investing activities
(13,239)
(6,734)
(11,478)
Cash from financing activities
(6,924)
(4,423)
(6,060)
FCF
8,961
36,006
3,009
Balance
Cash
527
231
165
Long term investments
44,205
Excess cash
38,874
Stockholders' equity
(56,339)
(57,535)
(57,853)
Invested Capital
142,292
146,211
138,044
ROIC
3.58%
2.88%
3.03%
ROCE
9.17%
5.73%
4.93%
EV
Common stock shares outstanding
21,707
21,646
21,547
Price
8.45
-19.83%
10.54
21.43%
8.68
-49.03%
Market cap
183,425
-19.60%
228,150
21.99%
187,031
-50.19%
EV
192,018
270,092
184,271
EBITDA
20,381
17,586
17,595
EV/EBITDA
9.42
15.36
10.47
Interest
1,777
2,170
1,402
Interest/NOPBT
22.55%
42.73%
33.11%